Compare EVC & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVC | PROF |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.8M | 270.7M |
| IPO Year | 2000 | 2017 |
| Metric | EVC | PROF |
|---|---|---|
| Price | $3.02 | $5.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 377.3K | 252.6K |
| Earning Date | 06-10-2026 | 06-16-2026 |
| Dividend Yield | ★ 6.69% | N/A |
| EPS Growth | ★ 47.59 | 25.89 |
| EPS | N/A | ★ 1.41 |
| Revenue | ★ $536,034,000.00 | $16,098,000.00 |
| Revenue This Year | N/A | $115.41 |
| Revenue Next Year | N/A | $60.63 |
| P/E Ratio | ★ N/A | $3.91 |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $1.76 | $3.90 |
| 52 Week High | $3.68 | $8.95 |
| Indicator | EVC | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 37.43 |
| Support Level | $2.85 | $5.45 |
| Resistance Level | $3.17 | $5.94 |
| Average True Range (ATR) | 0.17 | 0.57 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 18.02 | 26.14 |
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.